NCT05213078
- Conditions
- Lung Diseases, Lung Neoplasms, Malignant Female Reproductive System Neoplasm, +21 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Clinical trial condition
Stage IIIA Lung Cancer AJCC v8
Explore clinical trials studying Stage IIIA Lung Cancer AJCC v8. Study availability and eligibility vary by location and protocol.
50 public trials
13 recruiting studies
Stage IIIA Lung Cancer AJCC v8 trial results
NCT04229381
- Conditions
- Advanced Lung Carcinoma, Extensive Stage Lung Small Cell Carcinoma, Lung Diseases, +13 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
NCT04662645
- Conditions
- Caregiver, Hemic and Lymphatic Diseases, Lung Diseases, +22 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
NCT03902535
- Conditions
- Caregiver, Head and Neck Carcinoma, Lung Carcinoma, +25 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Completed
Patient Portal and Navigation Program in Providing Information for Asian American Cancer Patients
NCT03867916
- Conditions
- Caregiver, Colonic Diseases, Colorectal Neoplasms, +42 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
Active, Not Recruiting
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
NCT02194738
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +14 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Southern Cancer Center PC-Daphne Daphne, Alabama, United States
- Southern Cancer Center PC-Mobile Mobile, Alabama, United States
- Southern Cancer Center PC-Providence Mobile, Alabama, United States
Active, Not Recruiting
Genetically Engineered Natural Killer (NK) Cells With or Without Atezolizumab for the Treatment of Non-small Cell Lung Cancer Previously Treated With PD-1 and/or PD-L1 Immune Checkpoint Inhibitors
NCT05334329
- Conditions
- Advanced Lung Non-Small Cell Carcinoma, Bronchial Neoplasms, Carcinoma, Bronchogenic, +18 more
- Locations
-
- Chao Family Comprehensive Cancer Center University of California, Irvine Orange, California, United States
Active, Not Recruiting
Trametinib and Pembrolizumab in Treating Patients With Recurrent Non-small Cell Lung Cancer That Is Metastatic, Unresectable, or Locally Advanced
NCT03225664
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +17 more
- Locations
-
- Yale University New Haven, Connecticut, United States
- M D Anderson Cancer Center Houston, Texas, United States
NCT04092283
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
- Locations
-
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
- Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
Active, Not Recruiting
Testing the Addition of AZD6738 (Ceralasertib) to Immunotherapy to Increase Time Without Cancer for Patients With Non-Small Cell Lung Cancer
NCT06732401
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
- Locations
-
- NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States
- Tower Cancer Research Foundation Beverly Hills, California, United States
- Cedars-Sinai Medical Center Los Angeles, California, United States
- Cedars-Sinai Cancer - Tarzana Tarzana, California, United States